OrthoPediatrics Corp. (KIDS) News

OrthoPediatrics Corp. (KIDS): $47.75

-0.07 (-0.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter KIDS News Items

KIDS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

KIDS News Highlights

  • KIDS's 30 day story count now stands at 3.
  • Over the past 23 days, the trend for KIDS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest KIDS News From Around the Web

Below are the latest news stories about ORTHOPEDIATRICS CORP that investors may wish to consider to help them evaluate KIDS as an investment opportunity.

OrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report

WARSAW, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the publication of an Environmental, Social, and Governance (“ESG”) summary report. The report highlights how the Company’s commitment to diversity, inclusion and ethics underscores its mission to transform the lives of children with orthopedic conditions and provides a baseline of

Yahoo | February 1, 2023

Respiratory Infections Led OrthoPediatrics Miss Quarterly Sales Expectations, Analyst Calls It Transitory Issue

Monday, OrthoPediatrics Corp (NASDAQ: KIDS) preannounced 4Q22 revenue of $31.0 million (up 25%), which was below the consensus of $33.2 million. The company noted that increased respiratory illnesses (i.e., COVID, flu, RSV) caused procedural disruptions in pediatric hospitals and impacted its 4Q22 results. Needham writes that though Q422 results are disappointing, the respiratory illness surge is a transitory issue and expects growth to improve in 2023. Thus the analyst maintains the Buy rating.

Yahoo | January 10, 2023

OrthoPediatrics Corp. Announces Preliminary Unaudited Net Revenue for the Fourth Quarter & Full Year 2022, Provides Financial Outlook for 2023

WARSAW, Ind., Jan. 09, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2022, and provided 2023 financial guidance. Preliminary unaudited fourth quarter 2022 net revenue is expected to be $31.0 million, representing growth of 25% compared to $24.8 million in the f

Yahoo | January 9, 2023

OrthoPediatrics Corp. Establishes Direct Sales Organization in Germany

WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of its direct sales organization in Germany. OrthoPediatrics GmbH, commencing operations on January 1, 2023. OrthoPediatrics’ first direct international organization represents an expanding commitment to support pediatric orthopedics in international markets. “We

Yahoo | January 6, 2023

OrthoPediatrics Corp. to Host Educational and Networking Events at 18th Annual International Pediatric Orthopaedic Symposium (IPOS)

Continues IPOS Corporate Partnership as Double Diamond SponsorWARSAW, Ind., Dec. 05, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its continued support of the event as a Double Diamond sponsor. IPOS, a branch of the Pediatric Orthopedic Society of North America (POSNA), is a leading educat

Yahoo | December 5, 2022

OrthoPediatrics to Participate in Upcoming November Conferences

WARSAW, Ind., Nov. 04, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer and Chief Financial Officer, are scheduled to participate in fireside chats at two upcoming investor conferences. Event:Stifel 2022 Healthcare ConferenceFormat:Fireside ChatDate:Wednesday,

Yahoo | November 4, 2022

Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), OrthoPediatrics (KIDS) and BioNano Genomics (BNGO)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Esperion (ESPR – Research Report), OrthoPediatrics (KIDS – Research Report) and BioNano Genomics (BNGO – Research Report) with bullish sentiments. Esperion (ESPR) In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Esperion, with a price target of $14.00. The company's shares closed last Tuesday at $8.49. According to TipRanks.

Brian Anderson on TipRanks | November 1, 2022

Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN) and OrthoPediatrics (KIDS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aileron Therapeutics (ALRN – Research Report) and OrthoPediatrics (KIDS – Research Report). Aileron Therapeutics (ALRN) H.C. Wainwright analyst Edward White maintained a Hold rating on Aileron Therapeutics today. The company's shares closed last Tuesday at $0.20, close to its 52-week low of $0.13. According to TipRanks.

Christine Brown on TipRanks | November 1, 2022

OrthoPediatrics (KIDS) Reports Q3 Loss, Lags Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 73.68% and 4.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | October 31, 2022

OrthoPediatrics Corp. Reports Third Quarter 2022 Financial Results and Updates 2022 Revenue Guidance

Third Quarter 2022 Record Revenue Increased 39% Year-over-YearWARSAW, Ind., Oct. 31, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the third quarter ended September 30, 2022. Third Quarter 2022 and Recent Business Highlights Helped over 17,000 children in the third quarter 2022, bringing total to more than 610,000 since the

Yahoo | October 31, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6844 seconds.